[Immunopathological factors influencing the prognosis after resection of lung cancer]

Clicks: 350
ID: 261209
1990
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #4 of 9 articles by views in zhonghua wai ke za zhi [chinese journal of surgery]

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
118 surgical specimens were obtained from patients with lung cancer treated in our hospital during the period of 1977-1983 and tested with carcinoembryonic antigen (CEA), ABO (H) isoantigen and Concanavalin A (ConA). The results showed that the CEA assessment, which give no prognostic significance f …
Reference Key
yf1990zhonghua[immunopathological Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zhang YF;;
Journal zhonghua wai ke za zhi [chinese journal of surgery]
Year 1990
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/2269051
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis English Abstract carcinoma y f zhang adenocarcinoma / surgery squamous cell / surgery squamous cell / immunology pmid:2269051 abo blood-group system / immunology adenocarcinoma / immunology carcinoembryonic antigen / analysis concanavalin a / analysis isoantigens / analysis* lung neoplasms / immunology* lung neoplasms / surgery

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.